A Phase I Trial of Pevonedistat in Combination With Induction Chemotherapy for Adolescent and Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2018
At a glance
- Drugs Pevonedistat (Primary) ; Dexamethasone; Doxorubicin; Pegaspargase; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 01 Nov 2018 Planned End Date changed from 1 Sep 2024 to 1 Mar 2025.
- 01 Nov 2018 Planned primary completion date changed from 1 Sep 2023 to 1 Mar 2024.
- 31 Aug 2018 Biomarkers information updated